Lattice-tip Versus Irrigated-tip Catheter for Linear Ablation of the Cavotricuspid Isthmus. A Multicenter, Randomized Study.
Launched by MITERA HOSPITAL · Jul 12, 2025
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is comparing two types of catheters—tools used to treat abnormal heart rhythms—during a procedure called cavotricuspid isthmus (CTI) ablation. This procedure uses heat to create small scars in the heart tissue to stop irregular heartbeats. The study aims to find out which catheter, a standard irrigated-tip or a newer lattice-tip, is safer and works better by looking at how long the procedure takes, how many times the heat is applied, and whether there are any complications.
Adults over 18 years old who need this type of heart procedure and have not had previous ablations in the right side of their heart may be eligible to join. Participants can expect the usual CTI ablation procedure but with one of the two different catheters being tested. The study is currently recruiting and includes both men and women. This research could help doctors choose the best tools for treating certain heart rhythm problems more safely and effectively.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients above 18 years of age undergoing CTI ablation
- Exclusion Criteria:
- • Prior right atrium ablation
About Mitera Hospital
Mitera Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care and a focus on cutting-edge therapies, Mitera Hospital collaborates with a diverse network of healthcare professionals and researchers to conduct robust clinical studies. The hospital prioritizes patient safety and ethical standards, ensuring that all trials are designed to enhance the understanding of various conditions and contribute to the development of new treatment options. Its state-of-the-art facilities and expertise in clinical research position Mitera Hospital as a pivotal player in the healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Athens, Attikis, Greece
Patients applied
Trial Officials
Stylianos Tzeis, MD, PhD, FEHRA
Principal Investigator
Mitera Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported